You are here

antitrust

Sanofi's Provention buyout hit with FTC delay. Will Pfizer's Seagen deal go off as planned?

Fierce Pharma

Tue, 04/11/23 - 11:46 am

Viatris maintains legal winning streak with yet another EpiPen antitrust victory

Fierce Pharma

Mon, 04/3/23 - 10:51 pm

J&J finalizes $25M settlement, laying Remicade antitrust allegations to rest

Endpoints

Mon, 03/20/23 - 09:50 am

In Pfizer-Seagen review, FTC has chance to set new pharma precedent

BioPharma Dive

Tue, 03/14/23 - 06:28 pm

anticompetitive practices

In antitrust suit, Hikma says Amarin locked up exclusive supply deals to shut out Vascepa generics

Fierce Pharma

Fri, 02/24/23 - 08:55 am

Gilead, Teva and J&J's HIV antitrust case inches closer to trial as judge keeps most claims on the table

Fierce Pharma

Wed, 02/22/23 - 06:54 pm

Gilead Sciences

Teva Pharmaceutical

Novartis, Roche avoid $475M antitrust fine in French appeals court

Fierce Pharma

Mon, 02/20/23 - 12:57 pm

Illumina Could Face Hefty Fine Over Grail Acquisition

Medical Devices and Diagnostics Industry

Mon, 01/16/23 - 11:07 am

Novartis to pay $245 mln to end antitrust cases over Exforge drug generics

Reuters

Thu, 01/5/23 - 09:57 am

Is CVS' Acquisition of Signify in Danger of Falling Through?

Motley Fool

Thu, 09/15/22 - 10:32 am

Illumina defeats F.T.C. in major antitrust case

NY Times, NY

Thu, 09/1/22 - 07:46 pm

After delay, CSL's $11.7B deal for Vifor poised to close next week

Fierce Pharma

Tue, 08/2/22 - 10:39 am

Can Illumina Hold on to Grail?

Medical Devices and Diagnostics Industry

Tue, 08/2/22 - 12:01 am

Pfizer, Flynn Pharma slapped with £70 million fine for massive price hike on epilepsy drug

Fierce Pharma

Thu, 07/21/22 - 09:38 pm

Illumina loses challenge to block EU antitrust probe into $8B Grail buyout

Endpoints

Thu, 07/14/22 - 10:53 am

Regeneron's cholesterol drug war heats up with lawsuit over Amgen's 'illegal' bundling scheme

Fierce Pharma

Wed, 06/1/22 - 07:36 pm

As antitrust case wraps, Martin Shkreli's lawyers say they're owed $2M+ in unpaid legal fees

Endpoints

Wed, 04/13/22 - 10:32 am

AbbVie notches reprieve in antitrust case involving blood pressure med snagged in $63B Allergan megamerger

Fierce Pharma

Wed, 01/26/22 - 11:00 am

Antitrust regulators aim to revamp merger guidelines, signaling threat to health sector deals

BioPharma Dive

Sat, 01/22/22 - 02:10 pm

Shkreli hit with $64.6M verdict, lifetime pharma ban in antitrust case

Fierce Pharma

Sun, 01/16/22 - 03:58 am

Pages